COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,363 Articles (22,803 medRxiv, 8,560 bioRxiv)

Most recent first Previous |  Page 1143: Articles 11421-11430  | Next

Neurodevelopmental outcomes of infants secondary to in utero exposure to maternal SARS-CoV-2 infection: A national prospective study in Kuwait
Ayed, M., Embaireeg, A., Kartam, M., More, K., Alqallaf, M., AlNafisi, A., Alsaffar, Z., Bahzad, Z., Buhamad, Y., Alsayegh, H., AFouzan, W., Alkandari, H.
10.1101/2021.11.12.21266291 — Posted: 2021-11-14 Discussion: Onsite
Viral load and infectivity of SARS-CoV-2 in paired respiratory and oral specimens from symptomatic, asymptomatic or post-symptomatic individuals
Tallmadge, R. L., Laverack, M. A., Cronk, B., Venugopalana, R., Martins, M., Zhang, X., Elvinger, F., Plocharczyk, E., Diel, D.
10.1101/2021.11.13.21266305 — Posted: 2021-11-14
Implementation of Unassisted and Community-Based HIV Self-Testing (HIVST) during the COVID-19 pandemic among Men-who-have-sex-with-Men (MSM) and Transgender Women (TGW): A Demonstration Study in Metro Manila, Philippines
Rosadino, J. D. T., Pagtakhan, R. G., Brines, M. T., Dinglasan, J. L. G., Cruz, D. P., Corciega, J. O. L., Pagtakhan, A. B., Regencia, Z. J. G., Baja, E. S.
10.1101/2021.11.13.21266310 — Posted: 2021-11-14
Protection offered by mRNA-1273 versus BNT162b2 vaccines against SARS-CoV-2 infection and severe COVID-19 in Qatar
Abu-Raddad, L. J., Chemaitelly, H., Ayoub, H. H., Tang, P. J., Hasan, M. R., Coyle, P., YASSINE, H. M., Benslimane, F., Al-Khatib, H. A., Al-Kanaani, Z., Al Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul Rahim, H. F., Nasrallah, G., Al Kuwari, M. G., Butt, A. A., Al Romaihi, H. E., Al-Thani, M. H., Al Khal, A., Bertollini, R.
10.1101/2021.11.12.21266250 — Posted: 2021-11-13 Discussion: Onsite
An outbreak inside an outbreak: rising incidence of carbapenem-resistant isolates during the COVID-19 pandemic. Report from a tertiary care center in Argentina.
Castro, M. G., Ubiergo, L. I., Vicino, M., Cuevas, G., Argarana, F.
10.1101/2021.11.11.21266237 — Posted: 2021-11-12
Reducing false-positive SARS-CoV-2 diagnoses using long-range RT-qPCR
te Velthuis, A. J. W., Juozapaite, D., Rigby, C., Olendraite, I., Mathur, P., Dhanorkar, K., Hulle, V., Shah, T., Jadhao, V., Mutha, S., Jalal, H., Gopal, V.
10.1101/2021.11.11.21266219 — Posted: 2021-11-12 Discussion: Onsite
Quantification and progress over time of specific antibodies against SARS-CoV-2 in breast milk of lactating women vaccinated with BNT162b2 Pfizer-BioNTech COVID-19 vaccine (LacCOVID)
Esteve-Palau, E., Gonzalez-Cuevas, A., Guerrero, M. E., Garcia-Terol, C., Alvarez, M. C., Garcia, G., Moreno, E., Medina, F., Casadevall, D., Diaz-Brito, V.
10.1101/2021.11.11.21266119 — Posted: 2021-11-12 Discussion: Onsite
Myocarditis After mRNA-1273 Vaccination: A Population-Based Analysis of 151 Million Vaccine Recipients Worldwide
Straus, W., Urdaneta, V., Esposito, D. B., Mansi, J. A., Sanz Rodriguez, C., Burton, P., Vega, J. M.
10.1101/2021.11.11.21265536 — Posted: 2021-11-12
Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, January to September 2021.
Starrfelt, J., Buanes, E. A., Juvet, L. K., Lyngstad, T. M., Ro, G. O. I., Veneti, L., Meijerink, H.
10.1101/2021.11.12.21266222 — Posted: 2021-11-12 Discussion: Onsite
Machine Learning Based Prediction of COVID-19 Mortality Suggests Repositioning of Anticancer Drug for Treating Severe Cases
Linden, T., Hanses, F., Domingo-Fernandez, D., DeLong, L. N., Kodamullil, A. T., Schneider, J., Vehreschild, M. J. G. T., Lanznaster, J., Ruethrich, M. M., Borgmann, S., Hower, M., Wille, K., Feldt, T., Rieg, S., Hertenstein, B., Wyen, C., Roemmele, C., Vehreschild, J. J., Jakob, C. E. M., Stecher, M., Kuzikov, M., Zaliani, A., Froehlich, H., LEOSS study group
10.1101/2021.11.11.21266048 — Posted: 2021-11-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).